Vascular Pharmaceuticals, Inc., is a privately held drug development company developing VPI-2690B for complications of diabetes such as diabetic nephropathy. The company is headquartered in Chapel Hill, NC.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/12/12 | $16,000,000 | Series A |
Intersouth Partners MPM Capital | undisclosed |
| 03/05/15 | $9,000,000 | Series A Extension |
Intersouth Partners Lumira Capital MPM Capital | undisclosed |
